ObjectiveThere is a greater incidence of reproductive-related disorders among underweight as well as obese females resulting in trouble getting pregnant naturally and with ART. Extremes in Body Mass Index (BMI) have been negatively associated with clinical outcomes (Fedorcsak et, al), but a causal relationship remains unclear. Hormonal disturbances, elevated LDL and steroid precursors related to the additional adipose tissue in overweight and obese patients may affect endometrial, oocyte, and embryo quality. To determine if IVF patients with an altered BMI have similar blastocyst development rates, implantation, FHB and SAB as patients with a normal BMI.DesignRetrospective analyses of patients (n=594).Materials and Methods1245 cycles, 594 were candidates. Good blastocyst development defined as an ICM and trophectoderm grades of better than 3 (Grade of 1 = distinct ICM, cohesive trophectoderm, 2 = present ICM, good trophectoderm, 3 = small ICM, trophectoderm with mooning or too few cells). Fisher's exact test (two tailed P value) was used for statistical analysis.ResultsTable 1BMI% BLASTPRFHBIRSAB<19.972/219 33%*19/38 50%15/65 23%*19/65 29%*4/38 11%*20-24.24.9527/1703 31%*141/260 54%131/430 30%*141/430 33%*10/260 4%25-29.9447/1197 37%*90/172 52%89/290 31%90/290 31%1/172 0.5%*>30329/789 42%*62/124 50%53/119 45%*62/119 52%*10/126 8%** = statistically significant.Increasing rates of miscarriage were associated with increasing BMI values. Open table in a new tab ConclusionMaternal obesity effects clinical outcome. Endometrial receptivity as evidenced by implantation and miscarriage rates is more adversely affected by BMI changes than embryo quality. Women with extremes of BMI either too thin or too heavy have significantly higher pregnancy loss rates than those with ideal body weights implying an altered endometrial environment in these women. ObjectiveThere is a greater incidence of reproductive-related disorders among underweight as well as obese females resulting in trouble getting pregnant naturally and with ART. Extremes in Body Mass Index (BMI) have been negatively associated with clinical outcomes (Fedorcsak et, al), but a causal relationship remains unclear. Hormonal disturbances, elevated LDL and steroid precursors related to the additional adipose tissue in overweight and obese patients may affect endometrial, oocyte, and embryo quality. To determine if IVF patients with an altered BMI have similar blastocyst development rates, implantation, FHB and SAB as patients with a normal BMI. There is a greater incidence of reproductive-related disorders among underweight as well as obese females resulting in trouble getting pregnant naturally and with ART. Extremes in Body Mass Index (BMI) have been negatively associated with clinical outcomes (Fedorcsak et, al), but a causal relationship remains unclear. Hormonal disturbances, elevated LDL and steroid precursors related to the additional adipose tissue in overweight and obese patients may affect endometrial, oocyte, and embryo quality. To determine if IVF patients with an altered BMI have similar blastocyst development rates, implantation, FHB and SAB as patients with a normal BMI. DesignRetrospective analyses of patients (n=594). Retrospective analyses of patients (n=594). Materials and Methods1245 cycles, 594 were candidates. Good blastocyst development defined as an ICM and trophectoderm grades of better than 3 (Grade of 1 = distinct ICM, cohesive trophectoderm, 2 = present ICM, good trophectoderm, 3 = small ICM, trophectoderm with mooning or too few cells). Fisher's exact test (two tailed P value) was used for statistical analysis. 1245 cycles, 594 were candidates. Good blastocyst development defined as an ICM and trophectoderm grades of better than 3 (Grade of 1 = distinct ICM, cohesive trophectoderm, 2 = present ICM, good trophectoderm, 3 = small ICM, trophectoderm with mooning or too few cells). Fisher's exact test (two tailed P value) was used for statistical analysis. ResultsTable 1BMI% BLASTPRFHBIRSAB<19.972/219 33%*19/38 50%15/65 23%*19/65 29%*4/38 11%*20-24.24.9527/1703 31%*141/260 54%131/430 30%*141/430 33%*10/260 4%25-29.9447/1197 37%*90/172 52%89/290 31%90/290 31%1/172 0.5%*>30329/789 42%*62/124 50%53/119 45%*62/119 52%*10/126 8%** = statistically significant.Increasing rates of miscarriage were associated with increasing BMI values. Open table in a new tab * = statistically significant. Increasing rates of miscarriage were associated with increasing BMI values. ConclusionMaternal obesity effects clinical outcome. Endometrial receptivity as evidenced by implantation and miscarriage rates is more adversely affected by BMI changes than embryo quality. Women with extremes of BMI either too thin or too heavy have significantly higher pregnancy loss rates than those with ideal body weights implying an altered endometrial environment in these women. Maternal obesity effects clinical outcome. Endometrial receptivity as evidenced by implantation and miscarriage rates is more adversely affected by BMI changes than embryo quality. Women with extremes of BMI either too thin or too heavy have significantly higher pregnancy loss rates than those with ideal body weights implying an altered endometrial environment in these women.
Read full abstract